Tony Cataldo Enthusiastic About the Outcome of the Genesis Con. Call With the Investment Community
Chairman and CEO, Mr. Anthony Cataldo is positive about the outcome of the conference call with its investment community.
- (1888PressRelease) July 03, 2011 - Los Angeles, CA - Chairman and CEO of Genesis Biopharma Mr. Anthony Cataldo, is positive about the outcome of the conference call with the company's investment community. The conference call that was held on the 29th of June shall be re-telecast on July 1st. The conference call discussed about the clinical and commercial development plans for Contego, the company's new autologous cell therapy product candidate. The company under the aegis of its Chairman and CEO is in the development stage of cutting edge biotechnology research and is engaged in the development of targeted cancer therapies. Contego is the latest product designed to treat Stage IV Metastatic Melanoma.
For the uninitiated, Tony has been at the helm of affairs at Genesis Biopharma since February this year. He brings along with him a vast repertoire of experience in managing publicly traded companies. He has also been serving as the Chairman, CEO and a Director of Oxis International since 2009. Oxis is currently engaged in the research, development and sale of products that aim of counteract the effects of oxidative stress. A former employee of the US Air Force who served from 1969 to 1973, Tony Cataldo, carries with him the discipline and commitment towards work that has become synonymous of Air Force personnel. He has also been involved with BrandPatners Group Inc. as a Non Executive Chairman. The company is involved in the supply of integrated products and services and financial services with turn-key environmental solutions. He also led a turnabout of Multicell Technologies Inc., a supplier of functional, non tumorigenic immortalized human hepatocytes. The company that was struggling to keep its neck about waters from the debts that amounted to millions of dollars was revitalized by the efforts of Tony. Besides this he's also been in the board for Family Room Entertain Corp., Miracle Entertainment Inc., Calypte Biomedical Corp.etc.
Anthony Cataldo has also served as the President and Chairman of the Board of Senetek PLC, a biotechnology company that's involved in age-related therapies.
About Genesis Biopharma: The Company is engaged in the development of targeted cancer therapies.
To know more, visit http://www.hotstocked.com/officers/a/anthony-j-cataldo-34488.html